The Administrative Core provides leadership, direction, structure, oversight, and support for the Arizona Alzheimer's Disease Core Center (ADCC). It is responsible for the ADCC's performance, progress, and adherence to National Institute on Aging (NIA) guidelines. It is directly or indirectly responsible for the development, progress and support of numerous other programs in the Arizona Alzheimer's Consortium, its statewide collaborative model, the shared commitment of Arizona's researchers, organizations, and elected officials to its ADCC goals, and its extraordinary productivity, impact and growth. It helps ensure that our ADCC Cores and Ancillary Cores are optimally developed, productively used, advancing the fight against AD and related disorders, and improving the understanding of the aging mind and brain. It administers the ADCC's statewide program for the solicitation, competitive review, support and monitoring of NIA- and state-supported pilot projects. It helps attract promising researchers, trainees and students, and it supports their education, training, and research career development. It works with the ADCC's Internal Advisory Committee and participating organizations to leverage ADCC resources and further address its goals. It informs the ADCC's External Advisory Committee about its progress and plans and responds fully to the Committee's feedback and recommendations. It works closely with the NIA, National Alzheimer's Coordinating Center (NACC), National Cell Repository for AD (NCRAD), and Alzheimer's Association, other AD Centers, the ADCC's resulting programs and partnerships, numerous other organizations and stakeholder groups, and our Latino and Native American communities. It finds innovative and impactful ways to make a difference in the fight against AD, generate the collaborations, commitments and funding to make them successful, and play leadership roles in AD and cognitive aging research. During the proposed funding period, it will capitalize on recently announced organizational commitments and grants, dramatically increase the number of productive researchers, programs, and partnerships in Arizona, monitor its performances, and support the further development and use of its Cores. It will continue to make Arizona a model of statewide collaboration in AD research, a valued resource and partner to other researchers and programs, and a difference maker in the study of preclinical AD and the accelerated evaluation of AD prevention therapies. It will further increase Arizona's productivity and impact, help to address the ADCC's overarching goals, and seek to find and support the approval of effective AD prevention therapies within ten years.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG019610-19
Application #
9528416
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
19
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Arizona State University-Tempe Campus
Department
Type
DUNS #
943360412
City
Tempe
State
AZ
Country
United States
Zip Code
85287
Ting, Simon Kang Seng; Foo, Heidi; Chia, Pei Shi et al. (2018) Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. J Neuropsychiatry Clin Neurosci 30:31-37
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Ortuño-Lizarán, Isabel; Esquiva, Gema; Beach, Thomas G et al. (2018) Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson's disease. Acta Neuropathol Commun 6:90
Chakrabarty, Paramita; Li, Andrew; Ladd, Thomas B et al. (2018) TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's disease. J Exp Med 215:2247-2264
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Andrews, Megan; Tousi, Babak; Sabbagh, Marwan N (2018) 5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress. Neurol Ther 7:51-58
Grilli, Matthew D; Wank, Aubrey A; Bercel, John J et al. (2018) Evidence for Reduced Autobiographical Memory Episodic Specificity in Cognitively Normal Middle-Aged and Older Individuals at Increased Risk for Alzheimer's Disease Dementia. J Int Neuropsychol Soc 24:1073-1083
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826

Showing the most recent 10 out of 794 publications